The Effect of Slow-Paced Breathing on Patient Outcomes in Pulmonary Arterial Hypertension
NCT07232368 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2025-11-18
Summary
This study aims to investigate the effects of slow-paced breathing (SPB) intervention applied to patients with pulmonary arterial hypertension (PAH) in the home environment on symptom management (dyspnea, fatigue, sleep quality), clinical parameters (Six-Minute Walking Test-6MWT), IL-6, NT-proBNP results) and quality of life.
Conditions
- Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Interventions
- OTHER
-
Slow-paced breathing intervention
Other: Slow-paced breathing intervention After the intervention and control groups were determined, the purpose of the study was explained to both groups. Participants were informed that the intervention would last 12 weeks. Data collection forms would be completed face-to-face before the intervention (initial follow-up), during the 6th week (interim follow-up), and at the 12th week (final follow-up). Patients in the intervention group received a slow-paced breathing intervention in addition to the standard treatment protocol (verbal, video, and hands-on instruction, demonstration). After the first interview, participants received the application video (installed on a device such as a mobile phone, personal computer, and/or tablet, depending on the participant's preference and ease of use). The control group received only the standard treatment protocol. However, they were informed that they could perform the slow-paced breathing intervention upon completion of the study if they wished
Sponsors & Collaborators
-
Ege University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-11
- Primary Completion
- 2023-09-15
- Completion
- 2025-03-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension
NCT03401476 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.
NCT05908019 ·Status: UNKNOWN ·Phase: NA
-
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
NCT07073820 ·Status: RECRUITING ·Phase: PHASE2
-
Assessing the Utility of Submaximal CPET in Treatment Management of PAH
NCT05977933 ·Status: NOT_YET_RECRUITING
-
Oxygen Treatment and Pulmonary Arterial Hypertension
NCT03683082 ·Status: UNKNOWN ·Phase: NA
-
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
NCT03496623 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
NCT06137742 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Is the Two-minute Step Test an Alternative to the Six-minute Walk Test in Pulmonary Hypertension?
NCT07193173 ·Status: ACTIVE_NOT_RECRUITING
-
Acute Exposure of High Altitude on Cardiac Output
NCT03637218 ·Status: COMPLETED ·Phase: NA
-
Effects of Bosentan on Respiratory Mechanics
NCT00679068 ·Status: TERMINATED ·Phase: PHASE4
-
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
NCT01728220 ·Status: COMPLETED ·Phase: PHASE2
-
Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs
NCT03863990 ·Status: COMPLETED
-
Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension
NCT01548950 ·Status: COMPLETED ·Phase: NA
-
Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study
NCT05372263 ·Status: RECRUITING
-
Acute Exposure to High Altitude on Heart Rate and Ventilation During Exercise
NCT03593096 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
NCT02725372 ·Status: TERMINATED ·Phase: PHASE3
-
PAH Exercise Study
NCT06941441 ·Status: RECRUITING ·Phase: PHASE3
-
Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH
NCT03888365 ·Status: COMPLETED
-
Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension
NCT01523548 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor
NCT01458236 ·Status: WITHDRAWN ·Phase: PHASE3
-
Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis
NCT00567437 ·Status: TERMINATED ·Phase: NA
-
Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension
NCT04697875 ·Status: COMPLETED ·Phase: NA
-
Metabolic Remodeling in Pulmonary Arterial Hypertension (PAH)
NCT04968210 ·Status: COMPLETED
-
Acute Excposure of High Altitude on ECG and Non-invasive Blood Pressure.
NCT03593083 ·Status: COMPLETED ·Phase: NA
-
Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension
NCT00314548 ·Status: COMPLETED ·Phase: NA